Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 29, 2007

View Archived Issues

Recent Wellstat patents describe new treatment options for diabetes

Novel therapeutic agents for HIV infection reported in GSK patents

New treatment options for obesity and other metabolic disorders reported in patent literature

Pooled data show dose-related efficacy of fesoterodine in overactive bladder

Effect of KRP-204 on C-fiber urethral afferent nerves suggests benefit in urgency

Cannabinoids reduce contact hypersensitivity in mice

Effects of epratuzumab on B-cells examined in lupus patients

Arena prepares potential wake-promoting agents derived from natural compound

Candidates for the treatment of CCR4-mediated conditions identified at Astellas

Synthesis and in vivo antitumor activity of EC-0225 described at ACS meeting

FDA issues nonapprovable letter for IDM Pharma's mifamurtide NDA

Daiichi Sankyo reports approval of pediatric indication for Fentanyl injection in Japan

First patient treated in Protalix's phase III trial of prGCD for Gaucher's disease

Sanofi-aventis launches 200 mg single-use vial of Eloxatin

Positive results for ImmuneRegen's preclinical Radilex radiation study

Cobalis reports on study of PreHistin for the treatment of ragweed IgE

New LXR modulator with improved biological profile characterized at recent ACS meeting

New serotonin receptor antagonist for the treatment of incontinence described by Recordati

Novel selective norepinephrine reuptake inhibitor profiled by Wyeth

Rosiglitazone XR investigated in Alzheimer's disease

HemispheRx provides update on Alferon N in WNV and HPV projects

Pfizer and Bristol-Myers Squibb finalize collaboration agreement on DGAT-1 inhibitors

Celsion accelerates plans for ThermoDox phase I study in breast cancer

CuraGen and TopoTarget initiate phase I/II trial of combination therapy for AML

Indevus seeks FDA approval for male hypogonadism therapy

GlaxoSmithKline receives EC approval of Atriance for oncology orphan drug indications

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Gene therapies aim for the big goal of edits in vivo
BioWorld Science
The field of gene therapy is experiencing major advances driven by precise editing technologies, such as base and prime editing, and by the design of increasingly...